Thyroid metastasis revealing a lung adenocarcinoma: A case report and review of the literature.

Autor:	Elouarith I; Pathology Department, Ibn Sina Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, 10100 Rabat, Morocco. Electronic address: i.elouarith@gmail.com., Benbella L; Pathology Department, Ibn Sina Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, 10100 Rabat, Morocco., Arsalan O; General Surgery 'A' Department, Ibn Sina Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, 10100 Rabat, Morocco., El Malki HO; General Surgery 'A' Department, Ibn Sina Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, 10100 Rabat, Morocco., Znati K; Pathology Department, Ibn Sina Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, 10100 Rabat, Morocco., Jahid A; Pathology Department, Ibn Sina Hospital, Faculty of Medicine and Pharmacy, Mohammed V University, 10100 Rabat, Morocco.
Jazyk:	angličtina
Zdroj:	International journal of surgery case reports [Int J Surg Case Rep] 2022 Sep; Vol. 98, pp. 107525. Date of Electronic Publication: 2022 Aug 18.
DOI:	10.1016/j.ijscr.2022.107525
Abstrakt:	Introduction: Metastatic lung adenocarcinoma in the thyroid is very rare. The clinical presentation and the radiological findings for metastasis carcinoma are nonspecific and do not allow the distinction between metastatic lung carcinoma and primary thyroid tumor. Case Presentation: We report the case of a pulmonary papillary adenocarcinoma revealed by a thyroid metastasis in a 62-year-old and non-smoker patient with no history of cancer. Discussion: Thyroid metastasis revealing a primary adenocarcinoma of lung is extremely rare. In the absence of a history of lung cancer, the histological appearance of a papillary adenocarcinoma localized in the thyroid can be misdiagnosed as a primary thyroid cancer given the non-specificity of the clinical, radiological and histological presentations. Immunohistochemical analysis and molecular studies are the gold standards for establishing the diagnosis of the primary site. Conclusion: In this report we aim to discuss the histological and immunohistochemical features of lung adenocarcinoma metastazing in thyroid gland through a literature review. We are also targeting to highlight the essential role of immunohistochemistry and molecular study for the confirmation of the primary pulmonary origin and to discuss therapy for patients with lung cancer metastatic in the thyroid [17]. Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu